| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Surgery II, Osaka University Medical School, 1-1-50 Fukushima, Fukushima-ku, Osaka 553, Japan [Y. D., H. S., H. T., M. I., H. O., K. I., T. K., T. M.], and Department of Biophysics, Faculty of Science, Kyoto University, Kitashirakawa, Sakyo-ku, Kyoto 606, Japan [M. T.]
E-cadherin, a member of the cadherin family, plays a major role in cell-cell adhesion of normal epithelium. Recent studies have shown that reduction or loss of E-cadherin expression in carcinomas have some relationship with their clinicopathological manifestation including invasion and metastasis. In the present study, we have established cell clones with different E-cadherin expression from human esophageal cancer, TE-2, and examined their adhesive capacity and invasiveness in vitro. Cell clones with positive E-cadherin expression [ECD(+) cells] were round and formed cobblestone colonies, while cell clones negative for E-cadherin [ECD(-) cells] had spindle shapes and formed dispersed colonies. ECD(+) cells showed higher adhesive capacity than ECD(-) cells, in both an aggregation assay with gyratory shaking culture and a dissociation assay of cells passing through the micropore membrane. Monoclonal antibody against human E-cadherin (HECD1) effectively diminished the mutual adhesion of ECD(+) cells but did not affect that of ECD(-) cells. Tumor invasiveness was evaluated with organotypic raft culture which is a coculture system consisting of two layers, a collagen gel layer containing fibroblasts and overlying reconstituted stratified squamous epithelium. ECD(+) cells formed complete stratified epithelium, but ECD(-) cells did not. ECD(+) cells did not invade the collagen/fibroblast gel, but ECD(-) cells did. Furthermore, ECD(+) cells showed invasion when an antibody against E-cadherin was used. Thus, loss or dysfunction of E-cadherin diminishes intercellular adhesion and results in the acquisition of invasive capacity in the cell line we examined.
1 Supported in part by Grant-in-Aid for cancer research (No. 04454333) from the Ministry of Education, Science, and Culture, Japan.
2 To whom requests for reprints should addressed.
Received 3/ 4/93. Accepted 5/10/93.
This article has been cited by other articles:
![]() |
L. W. Wattenberg An interlocker concept of carcinogenesis. Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1425 - 1426. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Castelao, R. D. Bart III, C. A. DiPerna, E. M. Sievers, and R. M. Bremner Lung cancer and cyclooxygenase-2 Ann. Thorac. Surg., October 1, 2003; 76(4): 1327 - 1335. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. DiPerna, R. D. Bart, E. M. Sievers, Y. Ma, V. A. Starnes, and R. M. Bremner Cyclooxygenase-2 inhibition decreases primary and metastatic tumor burden in a murine model of orthotopic lung adenocarcinoma J. Thorac. Cardiovasc. Surg., October 1, 2003; 126(4): 1129 - 1133. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Troxell, D. Loftus, W. Nelson, and J. Marrs Mutant cadherin affects epithelial morphogenesis and invasion, but not transformation J. Cell Sci., January 3, 2001; 114(6): 1237 - 1246. [Abstract] [PDF] |
||||
![]() |
M. Kanke, M. Fujii, K. Kameyama, J. Kanzaki, Y. Tokumaru, Y. Imanishi, T. Tomita, and Y. Matsumura Role of CD44 Variant Exon 6 in Invasion of Head and Neck Squamous Cell Carcinoma Arch Otolaryngol Head Neck Surg, October 1, 2000; 126(10): 1217 - 1223. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Kozaki, O. Miyaishi, T. Tsukamoto, Y. Tatematsu, T. Hida, T. Takahashi, and T. Takahashi Establishment and Characterization of a Human Lung Cancer Cell Line NCI-H460-LNM35 with Consistent Lymphogenous Metastasis via Both Subcutaneous and Orthotopic Propagation Cancer Res., May 1, 2000; 60(9): 2535 - 2540. [Abstract] [Full Text] |
||||
![]() |
A. Shamma, H. Yamamoto, Y. Doki, J. Okami, M. Kondo, Y. Fujiwara, M. Yano, M. Inoue, N. Matsuura, H. Shiozaki, et al. Up-Regulation of Cyclooxygenase-2 in Squamous Carcinogenesis of the Esophagus Clin. Cancer Res., April 1, 2000; 6(4): 1229 - 1238. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |